跳至主要内容
临床试验/NCT04337424
NCT04337424已完成不适用

Evaluation of Quickly Diagnostic Saliva Tests for SARS-CoV-2

University Hospital, Montpellier2 个研究点 分布在 1 个国家目标入组 627 人开始时间: 2020年4月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
627
试验地点
2
主要终点
Specific detection of SARS-CoV-2 specific RNA

研究概览

简要总结

Coronavirus disease 2019 or COVID-19 is a highly contagious infectious disease. Symptoms of the disease are non-specific (fever, cough, dyspnea and fatigue), common with many seasonal viruses, which complicates the diagnosis. For mild forms, which represent the vast majority of cases, hospitalization is not necessary and treatment is symptomatic. However in more severe cases, hospitalization is required and sometimes even admission to an intensive care unit.

Several diagnostic tests are already available, but they require, in all cases, the intervention of qualified health personnel to carry out the sample, which includes a risk of contagion and an expensive and time-consuming laboratory analysis and reagents. These tests are therefore not very suitable for massive screenings.

We want to evaluate the performance of a detection test performed on a salivary sample in the diagnosis of SARS-CoV-2. This test will be non-invasive, performed without any analytical device and will restore its qualitative result "infected versus non-infected" in less than 1 hour (30min objective).

详细描述

Study taking place at the Montpellier University Hospital, comparing a salivary sample group with active infection (participants) for SARS-COV2 with a salavary sample tested negative (cured, convalescent and negative) for SARS-COV2 (healthcare workers ,participants)

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • - Control subjects (COV2- group): Participants ( Healthcare staff, patients and DRIVE participants) negative for SARS-CoV-2
  • - Infected subjects (COV2 + group): Patients diagnosed positive for SARS-CoV-2 hospital staff known to be positive and coming to do a control PCR DRIVE participants.

排除标准

  • Eligibility Criteria:
  • Inclusion Criteria:
  • - Control subjects (COV2- group): Healthcare staff presumed and diagnosed negative for SARS-CoV-2
  • - Infected subjects (COV2 + group): Patients diagnosed positive for SARS-CoV-2 hospital staff known to be positive and coming to do a control PCR
  • Exclusion Criteria:
  • Not affiliated with a French Social Security Systemscheme or equivalent system
  • Persons deprived of their liberty, adult protected under guardianship or vulnerable persons

结局指标

主要结局

Specific detection of SARS-CoV-2 specific RNA

时间窗: 1 day

Detection by the LAMP method is to be corroborated with the reference method, RT-PCR on the same salivary sample. Only one sample is taken per subject participating in the study. The sample is divided into two aliquots which will be analyzed by LAMP and RT-PCR

次要结局

  • Evaluation of the use of saliva samples compared to nasopharyngeal samples(1 day)
  • The correlation between the measurement of the assayed viral load (CT value) by the standard method and by the LAMP developed by SYS2DIAG / SKILLCELL.(1 day)
  • Analytical sensitivity of the LAMP test.(1 day)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Evaluation of Quickly Diagnostic Saliva Tests for... | 临床试验